Judi Health is a technology company.
Judi Health has raised $472.0M across 5 funding rounds.
Judi Health has raised $472.0M in total across 5 funding rounds.
Judi Health is a health technology company that provides an AI-powered enterprise health platform unifying pharmacy, medical, dental, and vision benefits administration on a single, scalable system called Judi®[1][2][4][8]. Originally evolving from Capital Rx, a pharmacy benefit manager (PBM), it now offers full-service solutions including claims processing, care navigation via Judi Care, and transparent pricing to reduce administrative waste and improve care coordination for employers, health plans, health systems, Medicare/Medicaid programs, and TPAs[1][2][5][8]. It serves millions of plan members, including those from Fortune 500 companies and major institutions, solving fragmentation in healthcare benefits by enabling real-time data sharing, plug-and-play integrations, and value-based care transitions[2][3][8].
The platform's growth momentum includes a rebrand from Capital Rx, a $400 million funding round, URAC accreditation, and live medical claims processing starting January 2025 for its own employees, positioning it as the industry's first unified claims processor[1][7][8].
Judi Health originated from Capital Rx, founded to transform prescription management with innovations like the first NADAC retail network[1]. Key milestones include closing Series B and C funding rounds, launching the Judi® enterprise health platform, a discount card solution, Medicaid/Medicare processing, and URAC accreditation[1]. In a pivotal evolution, Capital Rx rebranded to Judi Health after raising $400 million, expanding beyond pharmacy to unify all health benefits under its proprietary Judi platform—a cloud-native system for claims adjudication, prior authorizations, reporting, and more[1][8][9].
This shift emerged from developing internal technology to streamline benefits workflows, addressing inefficiencies in legacy systems and enabling an "unbundled" approach to health administration[1][9].
Judi Health rides the wave of value-based care and healthcare digitization, unifying fragmented silos (payers, providers, PBMs) amid rising costs and demands for precision medicine[2][3]. Its timing aligns with post-2025 shifts, like medical claims rollout and AI integration, capitalizing on market forces such as administrative waste reduction (e.g., harmonizing benefits that legacy systems ignore) and interoperability mandates[3][7]. By enabling holistic data visibility—e.g., syncing pharmacy fills with medical services—it influences the ecosystem toward collaborative, equitable outcomes, empowering health plans and employers to cut costs, speed treatments, and scale via cloud-native tech[1][2][4].
Judi Health is poised to dominate unified benefits administration as adoption grows among payers and employers seeking AI-driven efficiency[7][8]. Trends like generative AI expansion, deeper value-based models, and regulatory pushes for transparency will amplify its edge, potentially capturing more Medicare/Medicaid and enterprise clients through features like advanced Judi® updates[1][3][7]. Its influence may evolve into a standard "digital front door" for healthcare, further bridging gaps and redefining scalable, patient-centric administration—building directly on its mission to revolutionize access and affordability for all[1][5].
Judi Health has raised $472.0M in total across 5 funding rounds.
Judi Health's investors include B Capital Group, Edison Partners, General Catalyst, Transformation Capital, Al Gore.
Judi Health has raised $472.0M across 5 funding rounds. Most recently, it raised $250.0M Series F in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $250.0M Series F | B Capital Group, Edison Partners, General Catalyst, Transformation Capital, Al Gore | |
| Oct 1, 2023 | $50.0M Series D | B Capital Group, Edison Partners, General Catalyst, Transformation Capital, Al Gore | |
| Jun 1, 2022 | $110.0M Series C | B Capital Group, Edison Partners, General Catalyst, Transformation Capital, Al Gore | |
| Feb 1, 2021 | $50.0M Series B | B Capital Group, Edison Partners, General Catalyst, Transformation Capital, Al Gore | |
| Jul 1, 2019 | $12.0M Series A | B Capital Group, Edison Partners, General Catalyst, Transformation Capital, Al Gore |